Danaher Corp DHR

Morningstar Rating
$227.98 −1.72 (0.75%)
View Full Chart

Company Report

Price vs Fair Value

DHR is trading at a LOCK|Hy#z#^ premium.
Price
$229.75
Fair Value
n&!
Uncertainty
LOCK|DChh
1-Star Price
LOCK|l.@?X
5-Star Price
LOCK|t.DK
Economic Moat
LOCK|@&
Capital Allocation
LOCK|<^VWJvzF

Bulls Say, Bears Say

Bulls

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for Danaher's long-term prospects.

Bears

Danaher continues to hunt for acquisitions in the life sciences and diagnostics markets, which could constrain ROICs including goodwill if it makes acquisitions at unattractive prices and is not able to integrate them as successfully as in the past.

News

Articles & Videos

Trading Information

Previous Close Price
$233.86
Day Range
$226.67–230.55
52-Week Range
$160.93–242.79
Bid/Ask
$227.67 / $228.11
Shares Outstanding
702.99M
Market Cap
$161.51B
Volume/Avg
78,287 / 5M

Key Statistics

Price/Earnings (Normalized)
28.29
Price/Sales
6.36
Dividend Yield (Trailing)
0.65%
Dividend Yield (Forward)
0.68%
Dividend Payment Schedule
Jan, Apr, Jul, Oct
Total Yield
1.16%

Company Profile

In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Large Value
Total Number of Employees
60,000

Competitors

Valuation

Metric
DHR
RHHBY
MRK
Price/Earnings (Normalized)
28.2921.0917.63
Price/Book Value
3.019.392.05
Price/Sales
6.364.842.93
Price/Cash Flow
21.3515.1613.59
Price/Earnings
DHR
RHHBY
MRK

Financial Strength

Metric
DHR
RHHBY
MRK
Quick Ratio
1.080.800.99
Current Ratio
1.631.231.69
Interest Coverage
14.0213.497.22
Quick Ratio
DHR
RHHBY
MRK

Profitability

Metric
DHR
RHHBY
MRK
Return on Assets (Normalized)
5.55%15.81%4.75%
Return on Equity (Normalized)
9.14%48.77%8.32%
Return on Invested Capital (Normalized)
6.75%23.90%6.65%
Return on Assets
DHR
RHHBY
MRK

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|W>r^^$TLOCK|W#M$250B
Agilent Technologies Inc
A
LOCK|>j?@&qrLOCK|dFp$49B
IQVIA Holdings Inc
IQV
LOCK|ps@f^?VLOCK|TF?SQ$46B
Waters Corp
WAT
LOCK|VjR@j!fLOCK|K$$45B
IDEXX Laboratories Inc
IDXX
LOCK|C<S&&bkkLOCK|?>T$45B
Illumina Inc
ILMN
LOCK|<SFq$XLOCK|jc%h$41B
Mettler-Toledo International Inc
MTD
LOCK|rH#rt>^mLOCK|tTX#$34B
Quest Diagnostics Inc
DGX
LOCK|#M?WZ<LOCK|ysw$$27B
Labcorp Holdings Inc
LH
LOCK|<T$TrcMLOCK|^Q$ll$27B

Sponsor Center